digital health companies weight loss glp-1 private obesity management The Impact of Agonists on the MedTech Sector: Articulating a continued value proposition for devices GLP-1 Telehealth Is Changing Fast – Novo Nordisk seeks digital health

However, some studies show only small declines, while others have found more promising ones, so more research is needed

So it follows that continuing treatment helps preserve weight loss over time. Mir Ali, MD In the other placebo-controlled trial, SURMOUNT-MAINTAIN, the researchers investigated the efficacy and safety of maximum tolerated dose (MTD) tirzepatide and a lower 5 milligram (mg) dose for maintaining body weight reduction in adults with obesity

Common side effects may include: Most side effects are mild and temporary

Once mixed with liquid, refrigerate and use within about a month, and avoid freezing it again